GlassScriptPhysician profile
Trang Crabbe
NPI 1942446463
$11,040.41
in general payments reported to CMS, 2019-2025
30 companies · $1,418 in 2025
The $1,418 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,415 · 2022: $1,866 · 2023: $2,895 · 2024: $3,447 · 2025: $1,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,940 · Travel and Lodging: $754 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,939.95 |
| Travel and Lodging | $754.47 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,916.29 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Ffrangio |
| Shockwave Medical, INC | $2,037.79 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Amgen INC. | $1,605.18 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $789.25 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $592.05 | 2021-2025 | Eluvia, General - Balloons, Ekosonic |
| Actelion Pharmaceuticals US, INC. | $589.02 | 2021-2023 | Opsumit, Uptravi |
| Edwards Lifesciences Corporation | $378.68 | 2021-2025 | Evoque, Pascal |
| Bard Peripheral Vascular, INC. | $199.52 | 2023-2025 | Venclose Maven Catheter |
| Abiomed | $190.57 | 2022 | |
| Abbott Laboratories | $180.83 | 2021-2024 | Supera, Jeti, Jeti All In One Non-Sterile Kit |
| Penumbra, INC. | $158.91 | 2024 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $155.55 | 2022-2023 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $155.44 | 2023-2025 | Assure Wcd |
| Philips North America LLC | $146.74 | 2021-2024 | (Bq9) Coronary Ivus, (Br4) Coronary Undivided |
| Astrazeneca Pharmaceuticals LP | $134.59 | 2021-2023 | Farxiga |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $128.08 | 2024 | |
| Esperion Therapeutics, INC. | $105.77 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.80 | 2022-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $87.05 | 2023-2024 | Verquvo |
| Pfizer INC. | $76.97 | 2022-2023 | |
| Tactile Systems Technology INC | $55.85 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Surmodics, INC. | $50.08 | 2023 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Janssen Pharmaceuticals, INC | $41.54 | 2022 | |
| Cagent Vascular INC | $37.50 | 2025 | Serrantor |
| Chiesi USA, INC. | $34.84 | 2023 | Kengreal, Cleviprex |
| Novartis Pharmaceuticals Corporation | $27.77 | 2023 | |
| Becton, Dickinson and Company | $23.08 | 2025 | Venclose Maven Catheter |
| Recor Medical INC | $15.56 | 2024 | Paradise Renal Denervation System |
| Amarin Pharma, INC. | $13.63 | 2022 | |
| Cvrx, INC. | $11.48 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trang Crabbe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.